Oxford-AstraZeneca Covid 19 Vaccine Interview Part 2

Oxford-AstraZeneca Covid 19 Vaccine Interview Part 2

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the Oxford vaccine's initial and booster schedule, changes in guidance, and the need to adapt to evolving information during the pandemic. It highlights the importance of reaching vulnerable groups and the benefits of the vaccine's storage requirements for distribution. The focus is on maximizing vaccination numbers and improving efficiency, with an optimistic outlook on overcoming the pandemic.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the primary reason for extending the booster period to 12 weeks for the Oxford vaccine?

To improve the effectiveness of the vaccine

To reduce the number of doses required

To align with international guidelines

To allow more people to receive the initial dose

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How does the Oxford vaccine's storage requirement compare to the Pfizer vaccine?

It requires much lower temperatures

It needs the same storage conditions

It can be stored at higher temperatures

It requires no refrigeration

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is the ability to store the Oxford vaccine at higher temperatures significant?

It improves the vaccine's effectiveness

It allows for easier distribution to care homes

It reduces the cost of storage

It increases the vaccine's shelf life

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main operational goal of the vaccination program discussed?

To vaccinate only vulnerable groups

To set a fixed target for daily vaccinations

To maximize the number of vaccinations each day

To vaccinate only healthcare workers

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the general sentiment about the use of the Oxford vaccine in the community?

Skepticism about its effectiveness

Excitement about being among the first to use it

Concern over its side effects

Indifference towards its rollout